Group One Trading Portfolio holdings
AUM
$3.05B
1-Year Return
3.54%
This Quarter Return
+1.14%
1 Year Return
+3.54%
3 Year Return
+10.97%
5 Year Return
+15.65%
10 Year Return
+24.6%
AUM
$2.1B
AUM Growth
-$855M
(-29%)
Cap. Flow
-$1.03B
Cap. Flow
% of AUM
-48.78%
Top 10 Holdings %
Top 10 Hldgs %
24.64%
Holding
3,616
New
552
Increased
444
Reduced
696
Closed
635
Top Buys
| 1 |
Alibaba
BABA
|
+$83.1M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$43.5M |
| 3 |
Sarepta Therapeutics
SRPT
|
+$25M |
| 4 |
JPMorgan Chase
JPM
|
+$24.6M |
| 5 |
Netflix
NFLX
|
+$23.9M |
Top Sells
| 1 |
Cigna
CI
|
+$127M |
| 2 |
Microsoft
MSFT
|
+$75.9M |
| 3 |
Apple
AAPL
|
+$70.1M |
| 4 |
Meta Platforms (Facebook)
META
|
+$57.2M |
| 5 |
Scorpio Tankers
STNG
|
+$43.1M |
Sector Composition
| 1 | Technology | 24.87% |
| 2 | Consumer Discretionary | 17.15% |
| 3 | Financials | 10.98% |
| 4 | Healthcare | 10.56% |
| 5 | Communication Services | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1126
PDS Biotechnology
PDSB
$55.5M
| $29.9K | ﹤0.01% |
4,860
-4,839
| -50% | -$29.8K |
|
|
AMAM
1127
DELISTED
Ambrx Biopharma, Inc. Common Stock
AMAM
| $29.8K | ﹤0.01% |
+3,345
| New | +$29.8K |
|
1128
Cytosorbents Corp
CTSO
$61.3M
| $29.5K | ﹤0.01% |
8,763
+8,745
| +48,583% | +$29.5K |
|
|
AKTS
1129
DELISTED
AKOUSTIS TECHNOLOGIES, INC.
AKTS
| $29.4K | ﹤0.01% |
9,554
+4,645
| +95% | +$14.3K |
|
1130
Advent Technologies
ADN
$8.36M
| $29.4K | ﹤0.01% |
925
+179
| +24% | +$5.69K |
|
|
HPP
1131
Hudson Pacific Properties
HPP
$1.1B
| $29.3K | ﹤0.01% |
+4,400
| New | +$29.3K |
|
1132
Estee Lauder
EL
$31.4B
| $29.1K | ﹤0.01% |
118
-3,415
| -97% | -$842K |
|
1133
TETRA Technologies
TTI
$642M
| $29K | ﹤0.01% |
+10,947
| New | +$29K |
|
1134
GrafTech
EAF
$235M
| $29K | ﹤0.01% |
597
+466
| +356% | +$22.6K |
|
1135
National CineMedia
NCMI
$438M
| $29K | ﹤0.01% |
21,920
-8,011
| -27% | -$10.6K |
|
|
QNTM
1136
Quantum Biopharma Ltd. Class B Subordinate Voting Shares
QNTM
$58.8M
| $28.9K | ﹤0.01% |
287
+121
| +73% | +$12.2K |
|
1137
TriplePoint Venture Growth BDC
TPVG
$269M
| $28.8K | ﹤0.01% |
2,385
-384
| -14% | -$4.64K |
|
|
NTBL
1138
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
| $28.6K | ﹤0.01% |
4,871
-2,842
| -37% | -$16.7K |
|
1139
FS KKR Capital
FSK
$4.98B
| $28.5K | ﹤0.01% |
+1,539
| New | +$28.5K |
|
|
SLI
1140
Standard Lithium
SLI
$600M
| $28.3K | ﹤0.01% |
+7,436
| New | +$28.3K |
|
1141
Erasca
ERAS
$462M
| $28.2K | ﹤0.01% |
+9,364
| New | +$28.2K |
|
|
FUV
1142
DELISTED
Arcimoto, Inc. Common Stock
FUV
| $28K | ﹤0.01% |
+20,003
| New | +$28K |
|
|
BFX
1143
DELISTED
BowFlex Inc.
BFX
| $27.3K | ﹤0.01% |
20,395
+11,519
| +130% | +$15.4K |
|
1144
NiSource
NI
$19.3B
| $27.3K | ﹤0.01% |
977
+149
| +18% | +$4.17K |
|
1145
LiveOne
LVO
$61.8M
| $27.3K | ﹤0.01% |
23,908
+1,868
| +8% | +$2.13K |
|
|
IDEX
1146
DELISTED
Ideanomics, Inc. Common Stock
IDEX
| $27.1K | ﹤0.01% |
2,009
-115
| -5% | -$1.55K |
|
1147
Katapult Holdings
KPLT
$89.6M
| $27K | ﹤0.01% |
2,424
-592
| -20% | -$6.6K |
|
1148
EyePoint Pharmaceuticals
EYPT
$922M
| $26.8K | ﹤0.01% |
+9,120
| New | +$26.8K |
|
|
JBGS
1149
JBG SMITH
JBGS
$1.45B
| $26.8K | ﹤0.01% |
+1,778
| New | +$26.8K |
|
1150
8x8 Inc
EGHT
$290M
| $26.8K | ﹤0.01% |
6,420
-16,544
| -72% | -$69K |
|